BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2387381)

  • 1. [Pharmacological research on bonnecor and its metabolites].
    Poppe H; Heer S; Barch R
    Farmakol Toksikol; 1990; 53(3):46-8. PubMed ID: 2387381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
    Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
    Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
    Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
    Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiarrhythmic action of 3-carbethoxyamino-5-dimethylaminoacetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS -15) on experimental arrhythmia induced by aconitin, ouabain, calcium chloride and barium chloride].
    Femmer K; Poppe H; Heer S; Bartsch R
    Pharmazie; 1985 Dec; 40(12):836-40. PubMed ID: 3841597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The anti-arrhythmia properties of bonnecor metabolites].
    Grigor'eva EK; Poppe H; Tolmacheva EA; Krasnykh LM
    Farmakol Toksikol; 1990; 53(3):48-50. PubMed ID: 2387382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
    Senova ZP; Lyskovtsev VV; Grigor'eva EK; Gorbunova VV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):24-8. PubMed ID: 3761845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of the pharmacokinetics and pharmacodynamics of bonnecor].
    Rodionov AP; Lyskovtsev VV; Ignatova NA; Tolmacheva EA; Grigor'eva EK; Belinskiaia GF; Sheĭnberg BV
    Farmakol Toksikol; 1990; 53(3):40-3. PubMed ID: 1696909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between the physicochemical and pharmacokinetic parameters and the anti-arrhythmia activity of bonnecor and its metabolites].
    Rodionov AP; Zolotov NN; Lyskovtsev VV; Zalilov KIu; Poppe H
    Farmakol Toksikol; 1990; 53(3):50-1. PubMed ID: 2387383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
    Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
    Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The antifibrillatory properties of bonnecor].
    Grigor'eva EK; Gorbunova VV
    Farmakol Toksikol; 1990; 53(3):36-7. PubMed ID: 2387377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological study of quaternary trimecaine derivatives].
    Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP; Bukauskas FF
    Farmakol Toksikol; 1983; 46(4):36-40. PubMed ID: 6617835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiologic research on the anti-arrhythmia properties of bonnecor--a new dibenzazepine derivative].
    Berdiaev SIu; Marko R; Kelemen K; Darinskiĭ NV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):16-9. PubMed ID: 3531669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
    Lozinskiĭ LG; Zamotaev IP; Zeltyn'-Abramov EM; Orlov VA; Beloborodov VL; Kosilova EE; Zalesskaia MA; Tiukavkina NA
    Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog].
    Kaverina NV; Rodionov AP; Lyskovzev VV; Grigoreva JK; Sulakvelidze MT; Poppe H; Klemm W; Morgenroth U
    Pharmazie; 1985 Dec; 40(12):869-70. PubMed ID: 3841607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Search for and study of antiarrhythmic substances among crown ethers].
    Luk'ianenko NG; Bogatskiĭ AV; Iaroshenko IM; Vongaĭ VG; Nazarov EI
    Farmakol Toksikol; 1984; 47(5):29-32. PubMed ID: 6238839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic effects of the antiarrhythmic compound Bonnecor (AWD 19-166, GS 015).
    Nilius B; Schumann M
    Pharmazie; 1985 Dec; 40(12):854. PubMed ID: 3841601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An experimental study of the safety of the preparation bonnecor in trials on dogs].
    Kovalenko LP; Sorokina AV; Popova GR; Batanova OA; Liubimov BI
    Farmakol Toksikol; 1990; 53(3):54-7. PubMed ID: 2387384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical effects of the new antiarrhythmic compound Bonnecor (AWD 19-166, GS 015) under arrhythmogenic conditions.
    Nilius B
    Pharmazie; 1985 Dec; 40(12):855-6. PubMed ID: 3841602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.